SecSonar.com

Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Abeona Therapeutics Inc. (ABEO) is a Biotechnology company based in US with a market capitalization of $336M. Free cash flow was negative at -$84.3M. This page tracks ABEO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 136 employees · IPO Sep 19, 1980

Valuation

Valuation & price

$5.60 · as of May 15, 2026 · -22.5% vs 52w high

5.2

P/E ratio

Latest-FY diluted EPS

2.11

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.13$5.66$4.19Jul 25Dec 25Jul 26Jul 7, 25$5.75Jul 9, 25$5.83Jul 11, 25$5.74Jul 15, 25$5.95Jul 17, 25$6.63Jul 21, 25$6.75Jul 23, 25$6.71Jul 25, 25$6.53Jul 29, 25$6.75Jul 31, 25$6.37Aug 4, 25$6.42Aug 6, 25$6.39Aug 11, 25$6.28Aug 13, 25$6.56Aug 15, 25$7.13Aug 19, 25$6.84Aug 21, 25$7.11Aug 25, 25$7.01Aug 27, 25$6.90Aug 29, 25$6.83Sep 3, 25$6.95Sep 5, 25$6.89Sep 9, 25$6.83Sep 11, 25$6.75Sep 16, 25$5.68Sep 18, 25$5.64Sep 22, 25$5.48Sep 24, 25$5.55Sep 26, 25$5.44Sep 30, 25$5.28Oct 2, 25$5.32Oct 6, 25$5.34Oct 8, 25$5.54Oct 10, 25$5.36Oct 14, 25$5.35Oct 16, 25$5.47Oct 21, 25$5.47Oct 23, 25$5.42Oct 27, 25$5.54Oct 29, 25$4.99Oct 31, 25$4.81Nov 4, 25$4.56Nov 6, 25$4.19Nov 10, 25$4.23Nov 12, 25$4.94Nov 14, 25$4.45Nov 18, 25$4.48Nov 20, 25$4.22Nov 25, 25$4.88Nov 28, 25$5.07Dec 2, 25$4.55Dec 4, 25$4.87Dec 8, 25$5.13Dec 10, 25$5.47Dec 12, 25$5.36Dec 16, 25$5.00Dec 18, 25$4.92Dec 22, 25$5.44Dec 24, 25$5.41Dec 29, 25$5.37Jan 2, 26$5.31Jan 6, 26$5.16Jan 8, 26$5.09Jan 12, 26$5.10Jan 14, 26$5.19Jan 16, 26$5.25Jan 21, 26$5.31Jan 23, 26$5.16Jan 27, 26$5.11Jan 29, 26$5.08Feb 2, 26$5.17Feb 4, 26$5.08Feb 9, 26$5.13Feb 11, 26$5.06Feb 13, 26$5.01Feb 18, 26$5.12Feb 20, 26$5.26Feb 24, 26$5.40Feb 26, 26$5.20Mar 2, 26$5.06Mar 4, 26$4.97Mar 6, 26$4.85Mar 10, 26$5.14Mar 12, 26$4.96Mar 17, 26$4.76Mar 19, 26$4.54Mar 23, 26$4.42Mar 25, 26$4.42Mar 27, 26$4.29Mar 31, 26$4.48Apr 2, 26$4.82Apr 7, 26$4.81Apr 9, 26$5.12Apr 13, 26$5.06Apr 15, 26$5.40Apr 17, 26$5.50Apr 22, 26$5.63Apr 24, 26$5.39Apr 28, 26$5.36Apr 30, 26$5.46May 4, 26$5.95May 6, 26$6.01May 8, 26$5.90May 12, 26$5.68May 14, 26$5.60May 18, 26$5.37May 20, 26$5.32May 22, 26$5.44May 28, 26$5.78Jun 1, 26$5.63Jun 3, 26$5.67Jun 5, 26$5.46Jun 9, 26$5.45Jun 11, 26$5.53Jun 15, 26$5.67Jun 17, 26$5.65Jun 22, 26$5.75Jun 24, 26$5.62Jun 26, 26$5.61Jul 2, 26$6.40
$4.1752-week range$7.23
Loading valuation history…

Fundamentals

Key fundamentals

$336M

Market cap

—

Revenue growth (YoY)

73.7%

Gross margin

-$84.3M

Free cash flow (USD)

-$166.4M

Net debt

Net cash position

29.0%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$889.0KFY 2017$837.0KFY 2018$3.0MFY 2019$0.00FY 2020$10.0MFY 2021$3.0MFY 2022$1.4MFY 2023$3.5MFY 2024$0.00FY 2025$5.8M
$889K$5.8M

Free cash flow by year

2016 → 2025

FY 2016$-13.5MFY 2017$-23.8MFY 2018$-58.6MFY 2019$-69.3MFY 2020$-36.4MFY 2021$-69.8MFY 2022$-43.6MFY 2023$-37.3MFY 2024$-58.5MFY 2025$-84.3M
-$13.5M-$84.3M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 202268.2%FY 202354.1%FY 202573.7%
100.0%73.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

8

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $104KSilverstein Christine Berni · Director · $103.7KJun 15, 2026Filing
  • 8-K eventDirector ResignationJun 12, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • 8-K eventInvestor Presentation UpdateJun 10, 2026Filing
  • Insider sellInsider Sell $302KSeshadri Vishwas · Director, Chief Executive Officer · $301.9KJun 9, 2026Filing
  • Insider sellInsider Sell $52KVasanthavada Madhav · Chief Commercial Officer · $51.5KJun 9, 2026Filing
  • Insider sellInsider Sell $265K · 10b5-1 PlanVazzano Joseph Walter · Chief Financial Officer · $265.2KJun 9, 2026Filing
  • Insider sellInsider Sell $60KO'Malley Brendan M. · SVP, Chief Legal Officer · $59.6KJun 9, 2026Filing
  • 8-K eventPre-IND MeetingJun 4, 2026Filing
  • Insider sellInsider Sell $35KAlvino Mark · Director · $35.5KMay 22, 2026Filing

Questions

Frequently asked questions

What is Abeona Therapeutics Inc.'s market cap?

Abeona Therapeutics Inc. (ABEO) has a market capitalization of $336M.

What is ABEO's P/E ratio?

ABEO trades at a price-to-earnings ratio of 5.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ABEO's price-to-book (P/B) ratio?

ABEO trades at 2.11 times book value per share.

Are insiders buying ABEO stock?

SEC Form 4 filings show no open-market insider buys at Abeona Therapeutics Inc. in the last 90 days (8 sells).

Same arena

Related companies in Biotechnology

LCTX

Lineage Cell Therapeutics, Inc.

$334.1M

CMPX

Compass Therapeutics, Inc.

$334M

EDIT

Editas Medicine, Inc.

$331.4M

BCYC

Bicycle Therapeutics plc

$325.5M

EVMN

Evommune, Inc.

$324.9M

OABI

OmniAb, Inc.

$323.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.